Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsORALGeneric

AMVAZ

AMLODIPINE MALEATE

Standard Dose
2.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued

Key Takeaways

  • Primary indication: Review priority: STANDARD Marketing status: Discontinued
  • Approval overview AMVAZ is listed in Drugs@FDA under application 021435 (NDA).
  • Review priority: STANDARD Marketing status: Discontinued Active ingredient AMLODIPINE MALEATE Form and strength TABLET;ORAL - 2.5MG Sponsor DR REDDYS LABS INC Submission history Latest submission status date: 2003-10-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMVAZ is listed in Drugs@FDA under application 021435 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMLODIPINE MALEATE Form and strength TABLET;ORAL - 2.5MG Sponsor DR REDDYS LABS INC Submission history Latest submission status date: 2003-10-31 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.